Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Haleon plc American Depositary Shares (Each representing two Ordinary Shares) (NY:HLN)

8.850 -0.030 (-0.34%)
Streaming Delayed Price Updated: 9:32 AM EDT, Oct 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Haleon plc American Depositary Shares (Each representing two Ordinary Shares)

< Previous 1 2 3 Next >
Datadog, Compass Diversified, Transocean And This Consumer Health Company: CNBC's 'Final Trades'
On CNBC’s "Halftime Report Final Trades," Joseph Terranova of Virtus Investment Partners said "take a small position" in Datadog, Inc. (NASDAQ: DDOG). 
Via Benzinga
GSK: Add This Cheap Chip Play To Your Portfolio
GSK pays a decent quarterly dividend. The latest declared dividend is $0.35 per share, giving GSK a yield of 3.85%. 
Via Talk Markets
KVUE Stock: Should You Buy Into the Kenvue IPO?
KVUE stock will be a dividend stock with an initial yield of 3.5%, with slow growth and lower margins than JNJ's drug business. 
Via InvestorPlace
Pharma Giant Pfizer To Start Selling Haleon Stake Within Months, CFO Says
Pfizer Inc (NYSE: PFE) is reportedly looking to start selling its stake in Haleon plc (NYSE: HLN).  
Via Benzinga
Johnson & Johnson Unleashes Kenvue: Tylenol to Neutrogena, $40B Revenue Unit Spinoff Preps for IPO Blitz
 
Via Benzinga
Haleon & Microsoft Intend To Make Health Products More Accessible Via AI Technology
 
Via Benzinga
Dow Tumbles 150 Points; Tesla Shares Drop After Q1 Results
U.S. stocks traded lower this morning, with the Dow Jones dropping over 150 points on Thursday. Following the market opening Thursday, the Dow traded down 0.50% to 33,727.89 while the NASDAQ fell 0.49%... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 6, 2023
 
Via Benzinga
The Byzantine Adderall Shortage Puts Teva And Others In The Hot Seat
Millions of people are scrambling to get their ADHD medication. Here's why. 
Via Investor's Business Daily
Haleon PLC Announces Redemption of US$300,000,000 Outstanding Notes
Via ACCESSWIRE
Recent Stock Purchase/Sale February 2023
I have been busy buying up some stock this month and was happy to put some fresh and recycled capital to work to try and recoup some of my lost dividend income courtesy of the numerous cuts bestowed... 
Via Talk Markets
Jaguars 27-Point Comeback Costs Sports Bettor $1.4 Million: Here's How And Why No 'Sure Thing' Bet Is Safe
Have you heard the phrase "a sure thing" in sports? The phrase often refers to a sports match that has a winner declared by the public before the game starts, often a matchup between David vs. Goliath... 
Via Benzinga
The Viral “Tripledemic” Opportunity
Between Covid, the flu, and RSV, investors in over-the-counter consumer pharmaceutical companies might be wondering if now is a logical time to up their holdings in the companies that make cold and flu... 
Via Talk Markets
Forget Bonds, Buy Unilever
Unilever plc is a leading international consumer goods company, and one of the largest providers of personal care products. 
Via Talk Markets
Benzinga's Top Ratings Upgrades, Downgrades For September 28, 2022
Upgrades 
Via Benzinga
Burberry Finance Chief Joins GSK As First Woman CFO
 
Via Benzinga
Haleon Clocks Double Digit Growth In Interim Revenue, Profits; Sticks To Annual Guidance
 
Via Benzinga
Haleon Shares Pop After Rejecting Zantac Indemnification Requests From GSK, Pfizer
 
Via Benzinga
Earnings Scheduled For September 20, 2022
Companies Reporting Before The Bell • Apogee Enterprises (NASDAQ:APOG) is expected to report quarterly earnings at $0.83 per share on revenue of $344.64 million. 
Via Benzinga
Li Auto And Some Other Big Stocks Moving Lower In Today's Pre-Market Session
Turquoise Hill Resources Ltd. (NYSE: TRQ) shares fell 18.1% to $21.50 in pre-market trading after the company’s special committee rejected Rio Tinto’s offer worth $2.7 billion for the rest 49% stake in... 
Via Benzinga
Recalled Heartburn Pill Zantac Sets Fire To Glaxo and Sanofi Shares As Billions In Market Value Goes Up In Smoke
Sanofi SA (NASDAQ: SNY), GSK Plc (NYSE: GSK), and Haleon Plc (NYSE: HLN) have lost a combined $40 billion in mar 
Via Benzinga
Stocks That Hit 52-Week Lows On Thursday
  On Thursday, 22 companies reached new 52-week lows. 
Via Benzinga
GSK, PFE, SNY Stocks Fall on Zantac Litigation
You may think safety concerns about Zantac from 2019 are old news now, but GSK stock traders and others are worried about the repercussions. 
Via InvestorPlace
Pharma Stocks GSK, Sanofi And Haleon Lose Billions As Zantac Trial Looms
These companies are at the center of lawsuits claiming Zantac causes cancer. 
Via Investor's Business Daily
Why Is Disney Higher By More Than 7%: Here Are 40 Stocks Moving Premarket
Gainers 
Via Benzinga
Sonos, Bumble And Some Other Big Stocks Moving Lower In Today's Pre-Market Session
 
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
  During Wednesday, 52 stocks hit new 52-week lows. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 29, 2022
  
Via Benzinga
This Analyst Says GSK Spin-Off Haleon Offers "Best Of Both Consumer Worlds"
Citi group has initiated coverage on GSK plc's (NYSE: GSK) consumer healthcare spin-off Haleon Plc (NYSE: HLN) with a Buy rating and a price target of 360p. 
Via Benzinga
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.